PubMed

Systematic review: gene expression profiling assays in early-stage breast cancer.

Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, Goodman SN.

Ann Intern Med. 2008 Mar 4;148(5):358-69. Epub 2008 Feb 4. Review.PMID: 18252678 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of gene expression profiling tests on breast cancer outcomes.

Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, Goodman SN.

Evid Rep Technol Assess (Full Rep). 2007 Dec;(160):1-105. Review.PMID: 18457476 [PubMed - indexed for MEDLINE]Related articles

Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2009 Jan;11(1):66-73.PMID: 19125125 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM.

Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. Review.PMID: 18159035 [PubMed - indexed for MEDLINE]Related articles

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

Bueno-de-Mesquita JM, van Harten WH, Retel VP, van't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, van de Vijver MJ, Linn SC.

Lancet Oncol. 2007 Dec;8(12):1079-87. Epub 2007 Nov 26. Erratum in: Lancet Oncol. 2008 Jan;9(1):10. PMID: 18042430 [PubMed - indexed for MEDLINE]Related articles

Genomic predictors of outcome and treatment response in breast cancer.

Dunn L, Demichele A.

Mol Diagn Ther. 2009;13(2):73-90. doi: 10.2165/01250444-200913020-00002. Review.PMID: 19537843 [PubMed - indexed for MEDLINE]Related articles

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2008 Apr 2;299(13):1574-87.PMID: 18387932 [PubMed - indexed for MEDLINE]Related articlesFree article

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.

Ross JS.

Adv Anat Pathol. 2009 Jul;16(4):204-15. Review.PMID: 19546609 [PubMed - indexed for MEDLINE]Related articles

Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis.

Lyman GH, Kuderer NM.

Clin Breast Cancer. 2006 Dec;7(5):372-9.PMID: 17239261 [PubMed - indexed for MEDLINE]Related articles

Commercialized multigene predictors of clinical outcome for breast cancer.

Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobágyi GN.

Oncologist. 2008 May;13(5):477-93. Review. Erratum in: Oncologist. 2008 Aug;13(8). doi: 10.1634/theoncologist.2007-0248. PMID: 18515733 [PubMed - indexed for MEDLINE]Related articlesFree article

Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.

Nuyten DS, Hastie T, Chi JT, Chang HY, van de Vijver MJ.

Eur J Cancer. 2008 Oct;44(15):2319-29. Epub 2008 Aug 18.PMID: 18715778 [PubMed - indexed for MEDLINE]Related articles

Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

Asad J, Jacobson AF, Estabrook A, Smith SR, Boolbol SK, Feldman SM, Osborne MP, Boachie-Adjei K, Twardzik W, Tartter PI.

Am J Surg. 2008 Oct;196(4):527-9.PMID: 18809056 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling in breast cancer.

Morris SR, Carey LA.

Curr Opin Oncol. 2007 Nov;19(6):547-51. Review.PMID: 17906450 [PubMed - indexed for MEDLINE]Related articles

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer.

Conlin AK, Seidman AD.

Mol Diagn Ther. 2007;11(6):355-60. Review.PMID: 18078353 [PubMed - indexed for MEDLINE]Related articles

Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.

Cronin M, Sangli C, Liu ML, Pho M, Dutta D, Nguyen A, Jeong J, Wu J, Langone KC, Watson D.

Clin Chem. 2007 Jun;53(6):1084-91. Epub 2007 Apr 26.PMID: 17463177 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K.

BMC Cancer. 2008 Sep 8;8:254.PMID: 18778486 [PubMed - indexed for MEDLINE]Related articlesFree article

MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients.

Slodkowska EA, Ross JS.

Expert Rev Mol Diagn. 2009 Jul;9(5):417-22. Review.PMID: 19580427 [PubMed - indexed for MEDLINE]Related articles

Review of gene-expression profiling and its clinical use in breast cancer.

Stadler ZK, Come SE.

Crit Rev Oncol Hematol. 2009 Jan;69(1):1-11. Epub 2008 Jul 9. Review.PMID: 18614375 [PubMed - indexed for MEDLINE]Related articles

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.

Kaklamani V.

Expert Rev Mol Diagn. 2006 Nov;6(6):803-9.PMID: 17140367 [PubMed - indexed for MEDLINE]Related articles

Molecular profiling in breast cancer.

Morris SR, Carey LA.

Rev Endocr Metab Disord. 2007 Sep;8(3):185-98. Review.PMID: 17464566 [PubMed - indexed for MEDLINE]Related articles